Clinical Trial Update: Depemokimab Asthma Imaging and Bronchoscopy Sub-Study [Phase 3]

View source ↗

Summary

This Phase 3 sub-study of depemokimab in asthma, focusing on imaging and bronchoscopy, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Depemokimab (depemokimab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: RECRUITING